Barely Significant
← all phrases

“a decreasing trend”

47,181 sentences · 47,181 papers · 78,848 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

a decreasing trendP < 0.0010.0× alphagold
Ethnic groups and occupational characteristics of RR-PTB The proportion of Han ethnic group was the largest but showed a decreasing trend ( P < 0.001), the proportion of Miao ethnic group ranked second and showed an increasing trend ( P < 0.05), and the proportion of Tujia ethnic group maintained ( P > 0.05) (Fig. 2 A).
a decreasing trendp < 0.0010.0× alphagold
Hypertension and in‐hospital outcomes among breast cancer patients Within NIS, overall unadjusted in‐hospital mortality rates followed a decreasing trend among all groups over an extended period of time from 2003 to 2015 ( p ‐trend for breast cancer <0.001 as well as non‐cancer group p < 0.001, respectively); but was unchanged over the 2007 to 2015 period.
an increasing trendp < 0.0010.0× alphagold
a decreasing trendp = 0.0100.2× alphagold
For the T‐MoCA, the model examining the piecewise linear trend with knot at wave 3 (Model 0) showed an increasing trend in T‐MoCA before the knot (slope = 0.33 points per annual visit, SE = 0.07, p < 0.001), followed by the slope being reduced by 0.61 (SE = 0.15, p < 0.001) after the knot, resulting in a decreasing trend (slope = −0.27, SE = 0.11, p = 0.010).
a decreasing trendP ≤ 0.0010.0× alphagold
Across DUD subtypes, the prevalence of opioid use disorder was highest at 1 241.8/100 000 population (95% UI: 1 083.2 to 1 426.2) and this disorder had the largest increase (AAPC: 5.57%, 95% CI: 5.46% to 5.66%, P ≤ 0.001), while cannabis use was the only disorder with a decreasing trend (AAPC: −0.31%, 95% CI: −0.33% to −0.28%, P ≤ 0.001).
The rising burden of drug use disorders in the Americas, 2000-2021.
Rev Panam Salud Publica · 2025 · PMC12730193
a decreasing trendP < .0010.0× alphagold
MiR‐125b relative expression at W0, W4, W12, and W24 was 2.420 (1.578‐3.695), 1.937 (1.095‐2.603), 1.612 (0.798‐2.338), and 1.417 (0.676‐2.220), respectively, which also displayed a decreasing trend ( P < .001) (Figure 2C ). 3.5 Correlation of baseline miR‐125a and miR‐125b with clinical response to IFX at W24 in RA patients RA patients were divided into responders (n = 69; 71.9%) and non‐responders (n = 27; 28.1%) based on clinical response status at W24.